Systematic review / meta-analysis / 2021
Limited evidence supports high-dose micronutrient supplements for COVID-19, but preventing obesity and type 2 diabetes reduces serious outcome risks.
A systematic review synthesized data on 13 nutrition-related components and COVID-19 across 22 published articles, 38 preprint articles, and 79 trials identified up to August 2020. The authors found limited evidence that high-dose micronutrient supplements prevent severe disease or hasten recovery, with clinical trial results awaited. However, strong evidence indicates that the prevention of obesity and type 2 diabetes will reduce the risk of serious COVID-19 outcomes.
- Study type
- Systematic review
- Who was studied
- Studies including 22 published articles, 38 preprint articles, and 79 trials
- What was measured
- COVID-19 susceptibility, progression to symptoms, severe disease, and recovery
THE PAPER
The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.
James PT, Ali Z, Armitage AE, Bonell A, Cerami C, Drakesmith H, Jobe M, Jones KS, Liew Z, Moore SE, Morales-Berstein F, Nabwera HM, Nadjm B, Pasricha SR, Scheelbeek P, Silver MJ, Teh MR, Prentice AM. J Nutr, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.